CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PET3D ETN aims to enhance drug development efficiency through advanced molecular imaging techniques, particularly Positron Emission Tomography. The project trains researchers to address key questions in drug design, facilitating a smoother transition from preclinical to clinical phases.
The drug development strategy currently pursued by the pharmaceutical industry worldwide is inefficient and unsustainable for the health care system.
To keep the latter affordable, drug development should become more efficient and drug treatment should become more “personalized” and “rationalized”.
Molecular imaging can play a pivotal role in changing the landscape of drug design/development and improving the health care system.
Positron Emission Tomography (PET) imaging, in particular, is the t…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Bruxelles / Brussel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, Bergen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, San Sebastian
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
